Clinical Trial of Ruxian Zengsheng No. 1 Decoction
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
A prospective, open, randomized, controlled phase II clinical study is planned to clarify the
efficacy and related adverse reactions of Mammary Glandular Hyperplasia No. 1 Decoction in
the treatment of liver-qi stagnation type breast hyperplasia, relieve the pain of patients
with breast hyperplasia, and improve the quality of life of patients.